Amphetamines Urine Screen with Reflex to Quantitation
Also known as: AMP RFX U
Use
This test is useful for general screening in contexts such as compliance and abuse. It is designed to detect amphetamine exposure through a urine sample. A screen with reflex testing is the preferred method for ruling out amphetamine exposure due to its ability to provide both qualitative and quantitative results. For follow-up testing of a presumptive result, it is recommended to use the Amphetamines, Urine, Quantitative test (2010075).
Special Instructions
Not provided.
Limitations
Presumptive negative results for drugs and/or drug metabolites may indicate non-compliance, inappropriate timing of specimen collection relative to drug administration, poor drug absorption, diluted/adulterated urine, or limitations of testing. The concentration at which the screening test can detect a drug or metabolite may vary within a drug class, which is a limitation of testing. The test has not been cleared or approved by the US FDA and is only intended for clinical purposes.
New York Approved
Methodology
Mass Spectrometry
Biomarkers
LOINC Codes
- 19261-7 - Amphetamines Ur Ql Scn
- 54247-2 - Drug screen comment Ur-Imp
Result Turnaround Time
1-4 days
Related Documents
For more information, please review the documents below
Specimen
Urine
Volume
4.0 mL
Minimum Volume
2.0 mL
Container
ARUP Standard Transport Tube
Storage Instructions
Room temperature.
Causes for Rejection
Breast milk.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 1 week |
| Refrigerated | 1 month |
| Frozen | 1 month |
Other tests from different labs that may be relevant